Total Payments
$3,936
2024 Payments
$1,311
Companies
21
Transactions
242
Medicare Patients
3,727
Medicare Billing
$273,337
Payment Breakdown by Category
Food & Beverage$3,936 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,936 | 242 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,161 | 62 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $644.28 | 40 | $0 (2024) |
| ABBVIE INC. | $640.70 | 49 | $0 (2024) |
| Lilly USA, LLC | $382.70 | 33 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $244.45 | 7 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $167.74 | 10 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $136.82 | 8 | $0 (2024) |
| PFIZER INC. | $130.39 | 8 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $103.96 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $59.61 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,311 | 73 | Novo Nordisk Inc ($389.71) |
| 2023 | $1,033 | 63 | Novo Nordisk Inc ($364.02) |
| 2022 | $857.06 | 56 | Boehringer Ingelheim Pharmaceuticals, Inc. ($208.87) |
| 2021 | $734.58 | 50 | Novo Nordisk Inc ($219.75) |
All Payment Transactions
242 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: UROLOGY | ||||||
| 10/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Obesity | ||||||
| 10/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: DIABETES | ||||||
| 10/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: DIABETES | ||||||
| 10/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Cardiology | ||||||
| 10/01/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.95 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.64 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.70 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 741 | 1,396 | $141,409 | $51,180 |
| 2022 | 27 | 1,020 | 2,149 | $204,462 | $78,465 |
| 2021 | 28 | 1,061 | 2,491 | $216,967 | $98,179 |
| 2020 | 23 | 905 | 1,368 | $120,300 | $45,513 |
Total Patients
3,727
Total Services
7,404
Medicare Billing
$273,337
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 211 | 371 | $44,520 | $17,983 | 40.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 207 | $35,397 | $12,406 | 35.0% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 18 | 115 | $14,720 | $2,932 | 19.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 13 | 81 | $5,265 | $2,825 | 53.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 18 | 115 | $14,720 | $2,804 | 19.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 49 | 54 | $5,400 | $2,562 | 47.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 14 | 14 | $5,152 | $2,418 | 46.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 32 | 32 | $2,400 | $2,302 | 95.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 16 | 16 | $2,800 | $1,622 | 57.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 29 | 30 | $3,360 | $1,135 | 33.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 34 | $1,700 | $966.96 | 56.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 60 | 92 | $2,300 | $726.15 | 31.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 15 | 15 | $375.00 | $214.65 | 57.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 66 | 97 | $1,455 | $211.20 | 14.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 25 | 45 | $675.00 | $48.35 | 7.2% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 16 | 52 | $780.00 | $21.52 | 2.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 24 | 26 | $390.00 | $2.01 | 0.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 230 | 398 | $47,760 | $18,281 | 38.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 131 | 237 | $40,527 | $14,846 | 36.6% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2022 | 21 | 307 | $21,490 | $10,341 | 48.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 31 | 180 | $21,465 | $5,776 | 26.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 31 | 182 | $21,100 | $5,435 | 25.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 13 | 80 | $5,178 | $3,085 | 59.6% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 79 | 94 | $9,400 | $2,836 | 30.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 38 | 39 | $2,925 | $2,598 | 88.8% |
About Rita Koon, FNP BC
Rita Koon, FNP BC is a Family healthcare provider based in Union City, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/07/2010. The National Provider Identifier (NPI) number assigned to this provider is 1649500083.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rita Koon, FNP BC has received a total of $3,936 in payments from pharmaceutical and medical device companies, with $1,311 received in 2024. These payments were reported across 242 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($3,936).
As a Medicare-enrolled provider, Koon has provided services to 3,727 Medicare beneficiaries, totaling 7,404 services with total Medicare billing of $273,337. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Registered Nurse
- Location Union City, TN
- Active Since 01/07/2010
- Last Updated 07/30/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1649500083
Products in Payments
- JARDIANCE (Drug) $494.68
- Rybelsus (Drug) $398.05
- Ozempic (Drug) $388.51
- VRAYLAR (Drug) $267.12
- QULIPTA (Drug) $217.10
- TRULICITY (Drug) $194.61
- Wegovy (Drug) $178.78
- XARELTO (Drug) $167.74
- TRADJENTA (Drug) $161.39
- RYBELSUS (Drug) $155.97
- BREZTRI (Drug) $148.45
- MOUNJARO (Drug) $141.98
- UBRELVY (Drug) $138.35
- Kerendia (Drug) $136.82
- VOQUEZNA (Drug) $103.96
- FARXIGA (Drug) $79.73
- PREVNAR 20 (Biological) $67.72
- PAXLOVID (Drug) $62.67
- ENTRESTO (Drug) $59.61
- STIOLTO RESPIMAT (Drug) $34.32
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Union City
Yanet Rivas
Family — Payments: $10,797
Family $10,797
Laura Russell, Cfnp, CFNP
Family — Payments: $5,430
Family $5,430
Ms. Bernadette Ramos, Apn, APN
Family — Payments: $5,151
Family $5,151
Brenda Dexter, Fnp C, FNP C
Family — Payments: $4,920
Family $4,920
Amy Myers, Cfnp, CFNP
Family — Payments: $4,698
Family $4,698
Clay Marvin, Fnp, FNP
Family — Payments: $2,438
Family $2,438